ID   NHS_HUMAN               Reviewed;        1651 AA.
AC   Q6T4R5; B7ZVX8; E2DH69; Q5J7Q0; Q5J7Q1; Q68DR5;
DT   29-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   29-MAY-2013, sequence version 2.
DT   07-APR-2021, entry version 137.
DE   RecName: Full=Nance-Horan syndrome protein;
DE   AltName: Full=Congenital cataracts and dental anomalies protein;
GN   Name=NHS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND INVOLVEMENT
RP   IN NANCE-HORAN SYNDROME.
RX   PubMed=14564667; DOI=10.1086/379381;
RA   Burdon K.P., McKay J.D., Sale M.M., Russell-Eggit I.M., Mackey D.A.,
RA   Wirth M.G., Elder J.E., Nicoll A., Clark M.P., FitzGerald L.M.,
RA   Stankovich J.M., Shaw M.A., Sharma S., Gajovic S., Gruss P., Ross S.,
RA   Thomas P., Voss A.K., Thomas T., Gecz J., Craig J.E.;
RT   "Mutations in a novel gene, NHS, cause the pleiotropic effects of Nance-
RT   Horan syndrome, including severe congenital cataract, dental anomalies, and
RT   mental retardation.";
RL   Am. J. Hum. Genet. 73:1120-1130(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4).
RA   Dessay B., Ronce N., Kaplan J., Hartsfield J.K., Wallgren-Pettersson C.,
RA   Walpole I., Russo S., Chelly J., Moraine C., Toutain A.;
RT   "Identification of the gene involved in Nance-Horan syndrome.";
RL   Submitted (NOV-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=16675532; DOI=10.1093/hmg/ddl120;
RA   Sharma S., Ang S.L., Shaw M., Mackey D.A., Gecz J., McAvoy J.W.,
RA   Craig J.E.;
RT   "Nance-Horan syndrome protein, NHS, associates with epithelial cell
RT   junctions.";
RL   Hum. Mol. Genet. 15:1972-1983(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15772651; DOI=10.1038/nature03440;
RA   Ross M.T., Grafham D.V., Coffey A.J., Scherer S., McLay K., Muzny D.,
RA   Platzer M., Howell G.R., Burrows C., Bird C.P., Frankish A., Lovell F.L.,
RA   Howe K.L., Ashurst J.L., Fulton R.S., Sudbrak R., Wen G., Jones M.C.,
RA   Hurles M.E., Andrews T.D., Scott C.E., Searle S., Ramser J., Whittaker A.,
RA   Deadman R., Carter N.P., Hunt S.E., Chen R., Cree A., Gunaratne P.,
RA   Havlak P., Hodgson A., Metzker M.L., Richards S., Scott G., Steffen D.,
RA   Sodergren E., Wheeler D.A., Worley K.C., Ainscough R., Ambrose K.D.,
RA   Ansari-Lari M.A., Aradhya S., Ashwell R.I., Babbage A.K., Bagguley C.L.,
RA   Ballabio A., Banerjee R., Barker G.E., Barlow K.F., Barrett I.P.,
RA   Bates K.N., Beare D.M., Beasley H., Beasley O., Beck A., Bethel G.,
RA   Blechschmidt K., Brady N., Bray-Allen S., Bridgeman A.M., Brown A.J.,
RA   Brown M.J., Bonnin D., Bruford E.A., Buhay C., Burch P., Burford D.,
RA   Burgess J., Burrill W., Burton J., Bye J.M., Carder C., Carrel L.,
RA   Chako J., Chapman J.C., Chavez D., Chen E., Chen G., Chen Y., Chen Z.,
RA   Chinault C., Ciccodicola A., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Clerc-Blankenburg K., Clifford K., Cobley V., Cole C.G., Conquer J.S.,
RA   Corby N., Connor R.E., David R., Davies J., Davis C., Davis J., Delgado O.,
RA   Deshazo D., Dhami P., Ding Y., Dinh H., Dodsworth S., Draper H.,
RA   Dugan-Rocha S., Dunham A., Dunn M., Durbin K.J., Dutta I., Eades T.,
RA   Ellwood M., Emery-Cohen A., Errington H., Evans K.L., Faulkner L.,
RA   Francis F., Frankland J., Fraser A.E., Galgoczy P., Gilbert J., Gill R.,
RA   Gloeckner G., Gregory S.G., Gribble S., Griffiths C., Grocock R., Gu Y.,
RA   Gwilliam R., Hamilton C., Hart E.A., Hawes A., Heath P.D., Heitmann K.,
RA   Hennig S., Hernandez J., Hinzmann B., Ho S., Hoffs M., Howden P.J.,
RA   Huckle E.J., Hume J., Hunt P.J., Hunt A.R., Isherwood J., Jacob L.,
RA   Johnson D., Jones S., de Jong P.J., Joseph S.S., Keenan S., Kelly S.,
RA   Kershaw J.K., Khan Z., Kioschis P., Klages S., Knights A.J., Kosiura A.,
RA   Kovar-Smith C., Laird G.K., Langford C., Lawlor S., Leversha M., Lewis L.,
RA   Liu W., Lloyd C., Lloyd D.M., Loulseged H., Loveland J.E., Lovell J.D.,
RA   Lozado R., Lu J., Lyne R., Ma J., Maheshwari M., Matthews L.H.,
RA   McDowall J., McLaren S., McMurray A., Meidl P., Meitinger T., Milne S.,
RA   Miner G., Mistry S.L., Morgan M., Morris S., Mueller I., Mullikin J.C.,
RA   Nguyen N., Nordsiek G., Nyakatura G., O'dell C.N., Okwuonu G., Palmer S.,
RA   Pandian R., Parker D., Parrish J., Pasternak S., Patel D., Pearce A.V.,
RA   Pearson D.M., Pelan S.E., Perez L., Porter K.M., Ramsey Y., Reichwald K.,
RA   Rhodes S., Ridler K.A., Schlessinger D., Schueler M.G., Sehra H.K.,
RA   Shaw-Smith C., Shen H., Sheridan E.M., Shownkeen R., Skuce C.D.,
RA   Smith M.L., Sotheran E.C., Steingruber H.E., Steward C.A., Storey R.,
RA   Swann R.M., Swarbreck D., Tabor P.E., Taudien S., Taylor T., Teague B.,
RA   Thomas K., Thorpe A., Timms K., Tracey A., Trevanion S., Tromans A.C.,
RA   d'Urso M., Verduzco D., Villasana D., Waldron L., Wall M., Wang Q.,
RA   Warren J., Warry G.L., Wei X., West A., Whitehead S.L., Whiteley M.N.,
RA   Wilkinson J.E., Willey D.L., Williams G., Williams L., Williamson A.,
RA   Williamson H., Wilming L., Woodmansey R.L., Wray P.W., Yen J., Zhang J.,
RA   Zhou J., Zoghbi H., Zorilla S., Buck D., Reinhardt R., Poustka A.,
RA   Rosenthal A., Lehrach H., Meindl A., Minx P.J., Hillier L.W., Willard H.F.,
RA   Wilson R.K., Waterston R.H., Rice C.M., Vaudin M., Coulson A., Nelson D.L.,
RA   Weinstock G., Sulston J.E., Durbin R.M., Hubbard T., Gibbs R.A., Beck S.,
RA   Rogers J., Bentley D.R.;
RT   "The DNA sequence of the human X chromosome.";
RL   Nature 434:325-337(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 964-1651.
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   TISSUE SPECIFICITY, AND INVOLVEMENT IN NANCE-HORAN SYNDROME.
RX   PubMed=15466011; DOI=10.1136/jmg.2004.022517;
RA   Brooks S.P., Ebenezer N.D., Poopalasundaram S., Lehmann O.J., Moore A.T.,
RA   Hardcastle A.J.;
RT   "Identification of the gene for Nance-Horan syndrome (NHS).";
RL   J. Med. Genet. 41:768-771(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-401; SER-1176; THR-1262;
RP   SER-1329 AND SER-1499, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH TJP1/ZO-1.
RX   PubMed=19447104; DOI=10.1016/j.yexcr.2009.05.008;
RA   Sharma S., Koh K.S., Collin C., Dave A., McMellon A., Sugiyama Y.,
RA   McAvoy J.W., Voss A.K., Gecz J., Craig J.E.;
RT   "NHS-A isoform of the NHS gene is a novel interactor of ZO-1.";
RL   Exp. Cell Res. 315:2358-2372(2009).
RN   [11]
RP   INVOLVEMENT IN CTRCT40.
RX   PubMed=19414485; DOI=10.1093/hmg/ddp206;
RA   Coccia M., Brooks S.P., Webb T.R., Christodoulou K., Wozniak I.O.,
RA   Murday V., Balicki M., Yee H.A., Wangensteen T., Riise R., Saggar A.K.,
RA   Park S.M., Kanuga N., Francis P.J., Maher E.R., Moore A.T.,
RA   Russell-Eggitt I.M., Hardcastle A.J.;
RT   "X-linked cataract and Nance-Horan syndrome are allelic disorders.";
RL   Hum. Mol. Genet. 18:2643-2655(2009).
RN   [12]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=20332100; DOI=10.1093/hmg/ddq125;
RA   Brooks S.P., Coccia M., Tang H.R., Kanuga N., Machesky L.M., Bailly M.,
RA   Cheetham M.E., Hardcastle A.J.;
RT   "The Nance-Horan syndrome protein encodes a functional WAVE homology domain
RT   (WHD) and is important for co-ordinating actin remodelling and maintaining
RT   cell morphology.";
RL   Hum. Mol. Genet. 19:2421-2432(2010).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-332; THR-401; SER-415;
RP   SER-533 AND SER-739, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-865.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [15]
RP   VARIANT PRO-1628.
RX   PubMed=23092983; DOI=10.1038/tp.2012.102;
RA   Nava C., Lamari F., Heron D., Mignot C., Rastetter A., Keren B., Cohen D.,
RA   Faudet A., Bouteiller D., Gilleron M., Jacquette A., Whalen S., Afenjar A.,
RA   Perisse D., Laurent C., Dupuits C., Gautier C., Gerard M., Huguet G.,
RA   Caillet S., Leheup B., Leboyer M., Gillberg C., Delorme R., Bourgeron T.,
RA   Brice A., Depienne C.;
RT   "Analysis of the chromosome X exome in patients with autism spectrum
RT   disorders identified novel candidate genes, including TMLHE.";
RL   Transl. Psychiatry 2:E179-E179(2012).
RN   [16]
RP   VARIANT CYS-583.
RX   PubMed=26566883; DOI=10.1136/jmedgenet-2015-103179;
RA   Rafiullah R., Aslamkhan M., Paramasivam N., Thiel C., Mustafa G.,
RA   Wiemann S., Schlesner M., Wade R.C., Rappold G.A., Berkel S.;
RT   "Homozygous missense mutation in the LMAN2L gene segregates with
RT   intellectual disability in a large consanguineous Pakistani family.";
RL   J. Med. Genet. 53:138-144(2016).
CC   -!- FUNCTION: May function in cell morphology by maintaining the integrity
CC       of the circumferential actin ring and controlling lamellipod formation.
CC       Involved in the regulation eye, tooth, brain and craniofacial
CC       development. {ECO:0000269|PubMed:20332100}.
CC   -!- SUBUNIT: Interacts with the tight junction protein TJP1/ZO-1.
CC       Associates with actin-rich structures. Interacts with BRK1 and with all
CC       three members of the WAVE protein family, WASF1, WASF2 and WASF3.
CC       {ECO:0000269|PubMed:19447104, ECO:0000269|PubMed:20332100}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Apical cell membrane; Peripheral
CC       membrane protein. Cell projection, lamellipodium. Cell junction, tight
CC       junction. Cell junction, focal adhesion. Note=Colocalizes with the
CC       tight junction protein TJP1 in epithelial cells. Localizes to the
CC       leading edge of lamellipodia in motile cells.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=NHS-A;
CC         IsoId=Q6T4R5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6T4R5-2; Sequence=VSP_046541;
CC       Name=3; Synonyms=NHS-1A;
CC         IsoId=Q6T4R5-3; Sequence=VSP_046537, VSP_046540;
CC       Name=4;
CC         IsoId=Q6T4R5-4; Sequence=VSP_046538, VSP_046539, VSP_046540;
CC   -!- TISSUE SPECIFICITY: Detected at low levels in all tissues analyzed.
CC       Detected in fetal and adult brain, lens, retina, retinal pigment
CC       epithelium, placenta, lymphocytes and fibroblasts. Levels in retinal
CC       pigment epithelium, placenta, lymphocytes, and fibroblasts are very
CC       low. Expressed also in kidney, lung and thymus.
CC       {ECO:0000269|PubMed:14564667, ECO:0000269|PubMed:15466011}.
CC   -!- DISEASE: Nance-Horan syndrome (NHS) [MIM:302350]: Rare X-linked
CC       disorder characterized by congenital cataracts, dental anomalies,
CC       dysmorphic features, and, in some cases, mental retardation.
CC       Distinctive dental anomalies are seen in affected males, including
CC       supernumerary incisors and crown shaped permanent teeth. Characteristic
CC       facial features are anteverted pinnae, long face, and prominent nasal
CC       bridge and nose. Carrier females display milder variable symptoms of
CC       disease with lens opacities often involving the posterior Y sutures,
CC       and on occasion dental anomalies and the characteristic facial features
CC       described. {ECO:0000269|PubMed:14564667, ECO:0000269|PubMed:15466011}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Cataract 40 (CTRCT40) [MIM:302200]: An opacification of the
CC       crystalline lens of the eye that frequently results in visual
CC       impairment or blindness. Opacities vary in morphology, are often
CC       confined to a portion of the lens, and may be static or progressive.
CC       CTRCT40 manifests as a congenital nuclear opacity with severe visual
CC       impairment in affected males. Heterozygous females have suture
CC       cataracts and only slight reduction in vision. In some cases, cataract
CC       is associated with microcornea without any other systemic anomaly or
CC       dysmorphism. Microcornea is defined by a corneal diameter inferior to
CC       10 mm in both meridians in an otherwise normal eye.
CC       {ECO:0000269|PubMed:19414485}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry. Caused by copy number
CC       variations predicted to result in altered transcriptional regulation of
CC       the NHS gene: a 0.8 Mb segmental duplication-triplication encompassing
CC       the NHS, SCML1 and RAI2 genes, and an 4.8 kb intragenic deletion in NHS
CC       intron 1.
CC   -!- SIMILARITY: Belongs to the NHS family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY436752; AAR03104.1; -; mRNA.
DR   EMBL; AY456993; AAS13456.1; -; mRNA.
DR   EMBL; AY456992; AAS13455.1; -; mRNA.
DR   EMBL; GQ988776; ADN85614.1; -; mRNA.
DR   EMBL; AL845433; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z93242; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC136415; AAI36416.1; -; mRNA.
DR   EMBL; BC171763; AAI71763.1; -; mRNA.
DR   EMBL; CR749300; CAH18155.1; -; mRNA.
DR   CCDS; CCDS14181.1; -. [Q6T4R5-2]
DR   CCDS; CCDS48087.1; -. [Q6T4R5-3]
DR   RefSeq; NP_001129496.1; NM_001136024.3. [Q6T4R5-3]
DR   RefSeq; NP_001278796.1; NM_001291867.1. [Q6T4R5-1]
DR   RefSeq; NP_001278797.1; NM_001291868.1.
DR   RefSeq; NP_938011.1; NM_198270.3. [Q6T4R5-2]
DR   SMR; Q6T4R5; -.
DR   BioGRID; 110875; 24.
DR   ELM; Q6T4R5; -.
DR   IntAct; Q6T4R5; 17.
DR   STRING; 9606.ENSP00000369400; -.
DR   iPTMnet; Q6T4R5; -.
DR   PhosphoSitePlus; Q6T4R5; -.
DR   BioMuta; NHS; -.
DR   DMDM; 510120778; -.
DR   EPD; Q6T4R5; -.
DR   jPOST; Q6T4R5; -.
DR   MassIVE; Q6T4R5; -.
DR   MaxQB; Q6T4R5; -.
DR   PaxDb; Q6T4R5; -.
DR   PeptideAtlas; Q6T4R5; -.
DR   PRIDE; Q6T4R5; -.
DR   ProteomicsDB; 67371; -. [Q6T4R5-1]
DR   ProteomicsDB; 67372; -. [Q6T4R5-2]
DR   ProteomicsDB; 67373; -. [Q6T4R5-3]
DR   Antibodypedia; 24084; 27 antibodies.
DR   Ensembl; ENST00000380060; ENSP00000369400; ENSG00000188158. [Q6T4R5-2]
DR   Ensembl; ENST00000398097; ENSP00000381170; ENSG00000188158. [Q6T4R5-3]
DR   Ensembl; ENST00000676302; ENSP00000502262; ENSG00000188158. [Q6T4R5-1]
DR   GeneID; 4810; -.
DR   KEGG; hsa:4810; -.
DR   UCSC; uc004cxx.4; human. [Q6T4R5-1]
DR   CTD; 4810; -.
DR   DisGeNET; 4810; -.
DR   GeneCards; NHS; -.
DR   HGNC; HGNC:7820; NHS.
DR   HPA; ENSG00000188158; Low tissue specificity.
DR   MalaCards; NHS; -.
DR   MIM; 300457; gene.
DR   MIM; 302200; phenotype.
DR   MIM; 302350; phenotype.
DR   neXtProt; NX_Q6T4R5; -.
DR   OpenTargets; ENSG00000188158; -.
DR   Orphanet; 98991; Early-onset nuclear cataract.
DR   Orphanet; 627; Nance-Horan syndrome.
DR   Orphanet; 98994; Total early-onset cataract.
DR   PharmGKB; PA31622; -.
DR   VEuPathDB; HostDB:ENSG00000188158.14; -.
DR   eggNOG; ENOG502QSCT; Eukaryota.
DR   GeneTree; ENSGT00950000182963; -.
DR   InParanoid; Q6T4R5; -.
DR   OMA; AFVSPNK; -.
DR   OrthoDB; 60972at2759; -.
DR   TreeFam; TF333323; -.
DR   PathwayCommons; Q6T4R5; -.
DR   SIGNOR; Q6T4R5; -.
DR   BioGRID-ORCS; 4810; 7 hits in 611 CRISPR screens.
DR   ChiTaRS; NHS; human.
DR   GeneWiki; NHS_(gene); -.
DR   GenomeRNAi; 4810; -.
DR   Pharos; Q6T4R5; Tbio.
DR   PRO; PR:Q6T4R5; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q6T4R5; protein.
DR   Bgee; ENSG00000188158; Expressed in oviduct epithelium and 185 other tissues.
DR   ExpressionAtlas; Q6T4R5; baseline and differential.
DR   Genevisible; Q6T4R5; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005923; C:bicellular tight junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:HPA.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0002088; P:lens development in camera-type eye; IBA:GO_Central.
DR   InterPro; IPR024845; NHS_fam.
DR   Pfam; PF15273; NHS; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cataract; Cell junction; Cell membrane;
KW   Cell projection; Cytoplasm; Membrane; Phosphoprotein; Reference proteome;
KW   Tight junction.
FT   CHAIN           1..1651
FT                   /note="Nance-Horan syndrome protein"
FT                   /id="PRO_0000096810"
FT   REGION          1..262
FT                   /note="WAVE homology domain (WHD)"
FT   COMPBIAS        68..77
FT                   /note="Poly-Pro"
FT   COMPBIAS        112..117
FT                   /note="Poly-Ala"
FT   COMPBIAS        1475..1483
FT                   /note="Poly-Ser"
FT   MOD_RES         332
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         401
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         415
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         533
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         739
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1176
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         1262
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         1329
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         1499
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   VAR_SEQ         1..12
FT                   /note="MPFAKRIVEPQW -> MALACCMPKNAA (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_046537"
FT   VAR_SEQ         1..11
FT                   /note="MPFAKRIVEPQ -> MDNALFLCLAA (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_046538"
FT   VAR_SEQ         12
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_046539"
FT   VAR_SEQ         13..189
FT                   /note="Missing (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_046540"
FT   VAR_SEQ         285..305
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14564667"
FT                   /id="VSP_046541"
FT   VARIANT         583
FT                   /note="R -> C (in dbSNP:rs753449273)"
FT                   /evidence="ECO:0000269|PubMed:26566883"
FT                   /id="VAR_076438"
FT   VARIANT         865
FT                   /note="A -> T (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs149609550)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036225"
FT   VARIANT         1340
FT                   /note="F -> L (in dbSNP:rs3747295)"
FT                   /id="VAR_021527"
FT   VARIANT         1531
FT                   /note="S -> T (in dbSNP:rs2071848)"
FT                   /id="VAR_051234"
FT   VARIANT         1556
FT                   /note="S -> T (in dbSNP:rs2071848)"
FT                   /id="VAR_021528"
FT   VARIANT         1628
FT                   /note="A -> P"
FT                   /evidence="ECO:0000269|PubMed:23092983"
FT                   /id="VAR_076261"
FT   CONFLICT        305
FT                   /note="K -> KQ (in Ref. 1; ADN85614)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1651 AA;  179135 MW;  9B98C97BA0109F82 CRC64;
     MPFAKRIVEP QWLCRQRRPA PGPAVDASGG SAEPPPPLQP PGRRDLDEVE APGPEEPARA
     VPAPSGLPPP PPPLPAPADQ TQPPHGEASV AGEESTAGIP EAAPAAGEAS SAAAAAAVLL
     MLDLCAVSNA ALARVLRQLS DVARHACSLF QELESDIQLT HRRVWALQGK LGGVQRVLST
     LDPKQEAVPV SNLDIESKLS VYYRAPWHQQ RNIFLPATRP PCVEELHRHA RQSLQALRRE
     HRSRSDRREQ RAAAPLSIAA PPLPAYPPAH SQRRREFKDR HFLTFNSTRS PSPTECCHMT
     PWSRKSHPPE DEDTDVMLGQ RPKNPIHNIP STLDKQTNWS KALPLPTPEE KMKQDAQVIS
     SCIIPINVTG VGFDREASIR CSLVHSQSVL QRRRKLRRRK TISGIPRRVQ QEIDSDESPV
     ARERNVIVHT NPDPSNTVNR ISGTRDSECQ TEDILIAAPS RRRIRAQRGQ SIAASLSHSA
     GNISALADKG DTMFTPAVSS RTRSRSLPRE GNRGGDAEPK VGAKPSAYEE GESFVGDHER
     TPNDFSEAPS SPSAQDHQPT LGLACSQHLH SPQHKLSERG RSRLSRMAAD SGSCDISSNS
     DTFGSPIHCI STAGVLLSSH MDQKDDHQSS SGNWSGSSST CPSQTSETIP PAASPPLTGS
     SHCDSELSLN TAPHANEDAS VFVTEQYNDH LDKVRGHRAN SFTSTVADLL DDPNNSNTSD
     SEWNYLHHHH DASCRQDFSP ERPKADSLGC PSFTSMATYD SFLEKSPSDK ADTSSHFSVD
     TEGYYTSMHF DCGLKGNKSY VCHYAALGPE NGQGVGASPG LPDCAWQDYL DHKRQGRPSI
     SFRKPKAKPT PPKRSSSLRK SDGNADISEK KEPKISSGQH LPHSSREMKL PLDFANTPSR
     MENANLPTKQ EPSWINQSEQ GIKEPQLDAS DIPPFKDEVA ESTHYADLWL LNDLKTNDPY
     RSLSNSSTAT GTTVIECIKS PESSESQTSQ SESRATTPSL PSVDNEFKLA SPEKLAGLAS
     PSSGYSSQSE TPTSSFPTAF FSGPLSPGGS KRKPKVPERK SSLQQPSLKD GTISLSKDLE
     LPIIPPTHLD LSALHNVLNK PFHHRHPLHV FTHNKQNTVG ETLRSNPPPS LAITPTILKS
     VNLRSINKSE EVKQKEENNT DLPYLEESTL TTAALSPSKI RPHTANKSVS RQYSTEDTIL
     SFLDSSAVEM GPDKLHLEKN STFDVKNRCD PETITSAGSS LLDSNVTKDQ VRTETEPIPE
     NTPTKNCAFP TEGFQRVSAA RPNDLDGKII QYGPGPDETL EQVQKAPSAG LEEVAQPESV
     DVITSQSDSP TRATDVSNQF KHQFVMSRHH DKVPGTISYE SEITSVNSFP EKCSKQENIA
     SGISAKSASD NSKAEETQGN VDEASLKESS PSDDSIISPL SEDSQAEAEG VFVSPNKPRT
     TEDLFAVIHR SKRKVLGRKD SGDMSVRSKS RAPLSSSSSS ASSITSPSSN VTTPNSQRSP
     GLIYRNAKKS NTSNEEFKLL LLKKGSRSDS SYRMSATEIL KSPILPKPPG ELTAESPQST
     DDAHQGSQGA EALSPLSPCS PRVNAEGFSS KSFATSASAR VGRSRAPPAA SSSRYSVRCR
     LYNTPMQAIS EGETENSDGS PHDDRSSQSS T
//
